Risedronate Sodium Tablet, Delayed Release
Product Images NDC 59762-0407
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 59762-0407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Risedronate Sodium 02)
Principal Display Panelndc 59762-0407-4dispense The Enclosed Medicationguide To Each Patient4 Tabletsonce-a-weekgreenstone® Brandrisedronate Sodiumdelayed-release Tablets35 mgrx Only (Risedronate Sodium 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.